UCSF home page UCSF home page About UCSF Search UCSF UCSF Medical Center
UCSF navigation bar
AWBanner
Alternatives to the Use of Animals in Research
Species-Specific Information & Drug Formulary
Standard Procedures & Guidelines
Policies & Regulations
Animal Care & Use Program
How to Apply to the IACUC
Frequently Asked Questions
MHS Questionnaire
Meetings
Contacts
Forms
Notification/Fasting Request Form
Animal Welfare Concerns
For New Users
NEW PSB Classroom Presentation & Facility Orientation
Animal Research & Care
Laboratory Animal Resource Center
OR New Investigator Quick Guide
Policies & Guidelines
Mandatory Health Screening Policy
Training Program
Useful Links
What's New
Good Lab Practice (GLP)
Veterinary Services
Working Safely with Animals
RIO
Research Online (for online training)
Research News
THE INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE (IACUC)

IACUC / LARC STANDARD PROCEDURES

MHC-matched intravenous adoptive cell transfers

Description of procedure:
Adoptive Transfer Protocol:  A donor mouse is euthanized by UCSF standard procedures, and lymphoid cells from donor mice are prepared as a single cell suspension and adjusted to an appropriate final volume with sterile PBS.  Each mouse will receive 0. 1- 0.4 ml of cell suspension.  Cell numbers may vary between 1 x 10^4 and \1 x 10^8 cells.  Recipient mice are injected i.v. via tail vein or anesthetized and injected retro-orbitally using a small gauge (i.e. 30g) needleIf anesthetized, mice will be monitored continuously until ambulatory.

Mice will be evaluated for general appearance, ability to move normally around cage and reach food and water, ability to eat and drink, grooming habits, skin color, lethargy, aggression (animals will be housed individually if aggressive behavior is shown).

Literature search words required:

Literature search was performed for refinement of this Standard Procedure on Sept 1, 2006 :

Key Words Search Site Years Covered
Adoptive lymphocyte transfer Pubmed 1963-2009
Adoptive lymphocyte transfer Google No limit

Agents:

  • This procedure requires anesthetic for retro-orbital injection. All agents administered to animals should be listed in the “Agents” section of the protocol in RIO.

Adverse Effects:

Adverse Effects
Procedure, Agent or Phenotype Potential Adverse Effects Management
retrooribital injections trauma to the eye euthanasia
Cell transfer Graft vs. host disease euthanasia

Monitoring Parameters:

Monitoring Parameters
Monitoring Parameters Frequency PI/Lab will Document
General appearance/activity 2-3 times for 5 days then weekly thereafter No
Ability to eat & drink 2-3 times for 5 days then weekly thereafter No
Body condition score less than or equal to 2 2-3 times for 5 days then weekly thereafter Yes
Describe the conditions, complications, and criteria (e.g. uncontrolled infection, loss of more than 15% body weight, etc.) that would lead to removal of an animal from the study, and describe how this will be accomplished (e.g. stopping treatment, euthanasia).
Mice with Body Condition score less than or equal to 2 will be euthanized.
For all investigators housing animals with tumor formation, skin lesions, neurological deficits, or that are in Category E, list the expected characteristics/clinical presentations and endpoints of the animal model and the criteria for euthanasia. Note: The IACUC also requires such lists to be posted in the respective animal rooms and monitored by the IACUC compliance staff and LARC, to assure PI adherence to the endpoints listed.